Cite
HARVARD Citation
Koehm, M. et al. (2023). Methotrexate plus ustekinumab versus ustekinumab monotherapy in patients with active psoriatic arthritis (MUST): a randomised, multicentre, placebo-controlled, phase 3b, non-inferiority trial. Lancet. pp. e14-e23. [Online].